Target intelligence / Profile preview

SH3 domain-binding protein 4 (SH3BP4)

Target
SH3BP4
Molecular classification
Other (endocytic adaptor protein), Intracellular trafficking protein, Negative regulator of mTORC1 signaling
01

Overview

SH3 domain-binding protein 4 (SH3BP4) is an adaptor protein involved in the control of clathrin-mediated endocytosis and the trafficking of the transferrin receptor, containing motifs for interaction with endocytic and signaling proteins, including an SH3 domain, NPF repeats (EH domain-binding sites), and a death domain. SH3BP4 acts as a negative regulator of mTORC1 signaling by binding inactive Rag GTPase complexes, thereby impeding mTORC1 activation in response to amino acids. This regulatory function implicates SH3BP4 as a potential tumor suppressor, as deletions of the SH3BP4 locus are seen in several cancer types. SH3BP4 is highly conserved among vertebrates and is linked to both endosomal trafficking and cell signaling networks[1][2][3][4].

Other names
BOG25EHB10TTPEH-binding protein 10Transferrin receptor-trafficking protein
02

Mechanism of action

Inhibition of amino acid-induced activation of mTORC1 by binding inactive Rag GTPase complexes[2][4]

03

Biological functions

Clathrin-mediated endocytosisTransferrin receptor internalizationRegulation of mTORC1 signaling via Rag GTPase bindingIntracellular vesicle traffickingCell growth and proliferation regulationPotential modulation of apoptosis
04

Disease associations

Cancer (potential tumor suppressor, deletion observed in breast, renal, lung, and other tumor types[2][4])Charcot-Marie-Tooth disease type 1A[1]Molluscum contagiosum[1]

Beyond the preview

Go deeper on SH3 domain-binding protein 4 (SH3BP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SH3 domain-binding protein 4 (SH3BP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call